Author's posts
Dana-Farber launches gene therapeutics center
Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.
5 bird flu updates
Bird flu cases in humans are ticking up as the U.S. government funnels more than $300 million into strengthening its response to the outbreak and health experts find worrisome mutations in H5N1.
CVS Health launches CostVantage model
CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model.
Montefiore taps chief pharmacy officer
New York City-based Montefiore Health has appointed Ruth Cassidy, PharmD, as chief pharmacy officer.
8 must-have digital technologies for health systems in '25
In 2025, health system IT and digital leaders plan to focus on the common (data and cybersecurity) and the novel (creative voice artificial intelligence and inpatient digital “highways”).
EPA flags cancer risks tied to formaldehyde: 5 notes
Formaldehyde, a toxic chemical found in many common products, poses an “unreasonable risk” to human health, the Environmental Protection Agency said in a Jan. 2 report.
Epic CEO's lesson on caring
Judy Faulkner, founder and CEO of Epic Systems, has embedded “caring” into the company culture.
Systems face major winter storm: 5 notes
Numerous health systems in the path of a major winter storm moving across large swaths of the Midwest and Mid-Atlantic regions have closed clinics and are rescheduling elective procedures.
10 providers seeking RCM talent
Ten hospitals and health systems recently posted job listings seeking revenue cycle management expertise.
Massachusetts hospital audit finds 'startling' lack of oversight: 8 things to know
Massachusetts State Auditor Diana DiZoglio has found that the Center for Health Information and Analysis failed to monitor acute care hospitals’ financial conditions adequately, according to an audit released Jan. 3.
